Status: current, Defined. Date: 31-May 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4703391000168116 | Tolaze ODT (olanzapine 5 mg) orally disintegrating tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4703401000168119 | Tolaze ODT 5 mg orally disintegrating tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tolaze ODT 5 mg orally disintegrating tablet | Is a | Tolaze ODT | true | Inferred relationship | Some | ||
| Tolaze ODT 5 mg orally disintegrating tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Tolaze ODT 5 mg orally disintegrating tablet | Is a | olanzapine 5 mg orally disintegrating tablet | true | Inferred relationship | Some | ||
| Tolaze ODT 5 mg orally disintegrating tablet | has manufactured dose form | orally disintegrating tablet | true | Inferred relationship | Some | ||
| Tolaze ODT 5 mg orally disintegrating tablet | has unit of use | tablet | true | Inferred relationship | Some | 867696601 | |
| Tolaze ODT 5 mg orally disintegrating tablet | has Australian BoSS | olanzapine | true | Inferred relationship | Some | 1923154895 | |
| Tolaze ODT 5 mg orally disintegrating tablet | has intended active ingredient | olanzapine | true | Inferred relationship | Some | 1923154895 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tolaze ODT 5 mg orally disintegrating tablet, 28, blister pack | has TPUU | True | Tolaze ODT 5 mg orally disintegrating tablet | Inferred relationship | Some | 1785188084 |
| Tolaze ODT 5 mg orally disintegrating tablet, 28 | has TPUU | True | Tolaze ODT 5 mg orally disintegrating tablet | Inferred relationship | Some | 159140854 |
Reference Sets
Trade product unit of use reference set
FHIR